Phase III Randomized Study mFOLFOX7 or XELODA Plus Bevacizumab Versus Fluorouracil/Leucovorin Calcium or Capecitabine Plus Bevacizumab as First-Line Therapy in Elderly Patients With Metastatic Colorectal Cancer (No Drugs Provided)
NCCTG N0949 (MBMC Contact: Henry Robinson 314-996-5865)  Click For Consent

Phase III Randomized Study of Adjuvant FOLFOX Chemotherapy Comprising Oxaliplatin, Leucovorin Calcium, and Fluorouracil With Versus Without Celecoxib in Patients With Resected Stage III Colon Cancer (Celecoxib/Placebo Provided)
CALGB 80702 (MBMC Contact: Henry Robinson 314-996-5865)  Click For Consent *** 

A Phase III Trial of Irinotecan/5-FU/Leucovorin or Oxaliplatin/5-FU/Leucovorin with Bevacizumab, or Cetuximab (C225), or with the Combination of Bevacizumab and Cetuximab for Patients with Untreated Metastatic Adenocarcinoma of the Colon or Rectum (Cetuximab Provided)
CALGB 80405 (MBMC Contact: Henry Robinson 314-996-5865)  Click For Consent ***  (UPCOMING PERMANENT CLOSURE 2/15/12)

***Available through CTSU